SARS-CoV-2 neutralizing antibody bebtelovimab – a systematic scoping review and meta-analysis

INTRODUCTION: The COVID-19 pandemic is a major global public health crisis. More than 2 years into the pandemic, effective therapeutic options remain limited due to rapid viral evolution. Stemming from the emergence of multiple variants, several monoclonal antibodies are no longer suitable for clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Mabel Nyit Yi, Kua, Kok Pim, Lee, Shaun Wen Huey, Wong, Kon Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494534/
https://www.ncbi.nlm.nih.gov/pubmed/37701439
http://dx.doi.org/10.3389/fimmu.2023.1100263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494534/
https://www.ncbi.nlm.nih.gov/pubmed/37701439
http://dx.doi.org/10.3389/fimmu.2023.1100263

Ejemplares similares